CT Health Reform

CTNJ: CT health policy has trust issues

By Ellen Andrews | April 17, 2017

An OP-ED today in CT News Junkie describes the sorry level of mistrust in CT health policymaking. “Mistrust is pervasive…

April CT Health Reform Dashboard – temporary relief at federal level but troubling payment model returns (again and again and again)

By Ellen Andrews | April 5, 2017

CT’s April Health Reform Dashboard is somewhat more settled than last month – but that’s not a good thing. Efforts…

Analysts predict CT would lose $7 billion under the American Health Care Act

By Ellen Andrews | March 23, 2017

A new analysis by the Urban Institute finds that per capita caps on federal Medicaid spending under the American Health…

Medicaid Council update – PCMH + and national Medicaid proposals

By Ellen Andrews | March 20, 2017

Friday’s MAPOC meeting started with an update about the shared savings experiment that covers 137,037 members and started January 1st.…

Health reform dashboard reflects uncertainty, good and bad trends

By Ellen Andrews | March 3, 2017

March’s CT Health Reform Dashboard update reflects good, bad and uncertain policy movement in CT and DC. Most troubling is…

CT stuck at C+ grade for health reform, Mistrust is high and pervasive

By Ellen Andrews | March 1, 2017

Connecticut health care thought leaders again gave our state a C+ grade for health reform last month, but our GPA…

CT Health Reform Dashboard update reflects Medicaid concerns

By Ellen Andrews | February 1, 2017

February’s CT Health Reform Dashboard update reflects growing concerns about CT’s Medicaid program. Problems with the new EVV system threaten…

PCMH + evaluation plans – weak review and too late to matter

By Ellen Andrews | January 13, 2017

Wednesday DSS unveiled their initial plans to evaluate PCMH +, the new experimental HUSKY shared savings program that just started…

Cabinet begins to tackle prescription costs

By Ellen Andrews | January 11, 2017

CT’s Health Care Cabinet began drilling down into rising prescription drug costs and state options to stem the rise. We…